|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.92 USD | +2.86% |
|
+0.05% | +0.21% |
| 12/02 | Biogen Inc. Announces Board Changes | CI |
| 11/02 | RBC Raises Price Target on Exelixis to $46 From $45, Keeps Sector Perform Rating | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 46.61 | 46.61 | 46.24 |
| Spread/Res. | -5.77% | -5.77% | -5.02% |
| Spread/Supp. | +7.44% | +7.44% | +7.44% |
| Support | 40.88 | 40.88 | 40.88 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- EXEL Stock
- Charts Exelixis, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition